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Objectives. Robotic surgery enables to perform coronary surgery totally endoscopically. This report describes our experience using
the da Vinci system for coronary artery bypass surgery. Methods. Patients requiring single-or-double vessel revascularization were
eligible. The procedure was performed without cardiopulmonary bypass on a beating heart. Results. From April 2004 to May 2008,
ﬁfty-six patients were enrolled in the study. Twenty-four patients underwent robotic harvesting of the mammary conduit followed
by minimal invasive direct coronary artery bypass (MIDCAB), and twenty-three patients had a totally endoscopic coronary artery
bypass (TECAB) grafting. Nine patients (16%) were converted to open techniques. The mean total operating time for TECAB
was 372 ± 104 minutes and for MIDCAB was 220 ± 69 minutes. Followup was complete for all patients up to one year. There
was one hospital death following MIDCAB and two deaths at follow up. Forty-eight patients had an angiogram or CT scan
revealing occlusion or anastomotic stenoses (>50%) in 6 patients. Overall permeability was 92%. Conclusions. Robotic surgery
can be performed with promising results.
1.Introduction
Coronary artery bypass grafting (CABG) provides complete
revascularization with excellent long-term results and a low
mortality. However it generates signiﬁcant complications
and important costs. The tendency is actually to perform
operations through smaller and smaller incisions as to
reduce hospital stay and to fasten postoperative recov-
ery. More recently robotic-assisted thoracoscopic coronary
surgery provides the ability to perform revascularization
either totally endoscopic (TECAB) [1–3] or via small
thoracostomies (MIDCAB) [4–6]. Our institution initiated
robotic cardiac surgery in 2004 using the da Vinci surgical
system (Intuitive surgical, Sunnyvale, CA), and we have
completed over 150 cases of robotic cardiac surgeries. The
currentstudydescribesourexperiencewithroboticcoronary
artery revascularization, speciﬁcally addressing feasibility
safety and eﬃcacy while discussing its potential value and
limitations to the patient.
2. Patients andMethods
Patients with single-or-double vessel coronary artery disease
referred for surgical revascularization were eligible for the
study. We report our experience from April 2004 to June
2008 which includes 56 patients. All patients gave informed
consentforcoronaryarterybypasssurgeryusingthedaVinci
surgical system (ﬁrst generation).
2.1. Training Protocol. Before starting the series we under-
went a stepwise training program including basic da
Vinci training, robotically-assisted IMA mobilizations, and
TECAB speciﬁc training.
2.2. Inclusion and Exclusion Criteria. All patients considered
eligible for enrollment were reviewed by a surgeon and a
cardiologist who reviewed all coronary angiograms. Patients
whohadasingleoccludedarteryoraninstentrestenosiswere2 Cardiology Research and Practice
considered, as well as patient with double-vessel lesion, or
patients who could beneﬁt from a hybrid procedure. Hybrid
procedures were deﬁned as patients with two lesions: one
which could easily be treated by angioplasty, whereas the
other lesion was better suited for surgical revascularization
(occluded artery, long calciﬁed type C lesion).
All patients had a preoperative surgical and anesthesiol-
ogist visit which included medical history, physical examina-
tion, pulmonary function tests, computer tomography of the
chest and/or gated coronary CT scan, and echocardiography.
Based on the information and the established inclusion-
exclusion criteria the patient was oﬀered robotically-assisted
coronary revascularization. Exclusion criteria included left
ventricular ejection fraction <0.30, emergency surgery, pul-
monary edema, inability to ventilate on one lung (asthma,
chronic obstructive pulmonary disease, pulmonary ﬁbrosis),
hemodynamicinstability,anatomyunsuitableforendoscopic
surgery (scoliosis, kyphosis, morbid obesity), previous lung
surgery, pleural adhesions visible on CT scan, and patient
unwilling to sign an informed consent.
Depending on the location of the coronary as well as
the caliber and the degree of calciﬁcations, a TECAB or a
MIDCAB was chosen. If the circumﬂex or the right coronary
arteries needed to be revascularized, a MIDCAB was chosen,
as well as for patients needing a double revascularization
left anterior descending (LAD) diagonal. A TECAB was
proposed only for patients in need of revascularization of an
LAD or a large diagonal branch.
2.3. Operative Technique. Anesthesia was slightly modiﬁed
compared to patients undergoing CABG with ECC. Betablo-
cants are continued in the hospital and given the day of
surgery in order to maintain a cardiac rhythm between
50 and 60 beats per minute. Anesthesia was maintained
with reduced doses, Sulfentanyl (Sufenta) 2mcg/kg, Fluri-
trazepam (Narcozep) 0.03mg/kg, and Bromure of Pancuro-
nium (Pavulon) 0,1mg/kg, associated with an inhalation
agent (Enﬂurane, Ethrane). In case of tachycardia heart
rate can be slowed with intrasvenous betablocking agents
(Esmolol IV), or calcium channel blockers (Diltiazem). All
patients were monitored with a radial continuous cardiac
output monitor.
Heparin doses were reduced 50UI/Kg IV, without any
protamin reversal.
Ad o u b l e - l u m e ne n d o t r a c h e a lt u b ei sp l a c e dd u r i n gt h e
surgery; it is subsequently changed to a single-lumen tube at
the end of the procedure.
A camera was inserted through a 5th intercostal space
midaxillary line and two 8mm robotic instruments trocars
were placed in the 2nd and 7th intercostal space midaxillary
line in order to obtain a triangulation with the camera. The
left or right mammary artery was dissected entirely from
its insertion on the subclavian artery to its bifurcation. The
pericardium was then open over the target vessel and an
endoscopic stabilizer was inserted through a 12mm port
placed in the subxiphoid region and positioned over the
target vessel. After heparinization, occlusion of the artery
was done with silastic loops; arteriotomy was performed as
an end to side anastomosis using running 8-0 monoﬁlament
(Goretex or Prolene) sutures. At completion of the anasto-
mosis all trocars are removed and two chest tubes are placed.
During mammary harvesting both lungs were venti-
lated while during coronary artery anastomosis single right
lung ventilation was maintained. The procedure has been
described in detail in other studies [7, 8].
All TECAB or MIDCAB was performed with the endo-
scopic stabilizer which was either placed Trans xiphoid or
directlythroughtheminithoracicincision.Inﬁfteenpatients
with incomplete coronary artery occlusion, we placed a
coronary shunt, and the anastomosis was performed over
a shunt. No patient needed pump assistance through groin
cannulation.
When a double bypass was performed, both mammary
arteries were harvested through the left chest. The anasto-
mosis of the right mammary artery to the right coronary
wasmadethroughasmall4thrightintercostalsthoracotomy.
The endostabilizer was placed directly through the incision
and the anastomosis was hand sawn. When the circumﬂex
arterywaschosen,theincisionwasslightlymoreposterioron
the left 4th intercostals space. The endo stabilizer was placed
through the incision, and the anastomosis was hand made.
2.4. Exclusion versus Conversion. Once the patients were
enrolled, the surgical team decided to perform either a
MIDCAB or a TECAB. Intraoperative conversions were
deﬁned as cases in which a TECAB was scheduled but had
to be abandoned for various reasons and converted to either
a MIDCAB or a midline sternotomy.
2.5. Followup Postoperative Assessment. All immediate post-
surgical clinical information was recorded per standard
hospital practice and this included a postoperative 12-lead
ECG, chest X-ray, cardiac enzymes, and echocardiogram.
Patients had a followup visit between one to three
months. Supplemental postoperative studies and physical
exam, resting 12-lead ECG, stress ECG or SPECT, and
transthoracic echo were obtained. All patients were oﬀered a
control angiogram after three months, and in case of refusal,
a gated CT scan was performed. All angiograms or CT scan
was seen and reviewed by the team which included a surgeon
and an angiographer.
All information was prospectively entered in the data-
base.
All patients continued to be followed through regular
information obtained by the referring cardiologist.
Comparisons between groups were performed by the
standard X2 test (or Fisher’s exact test when an expected
frequency was less than 5) to compare categorical variables
andoperativemortality,andthet testtocomparecontinuous
variables. Statistical signiﬁcance was accepted at P < .05.
3. Results
3.1. Patient Population. A total of 56 patients were poten-
tial candidates for robotic-assisted surgery and agreed to
sign an informed consent. Demographics and baselineCardiology Research and Practice 3
Table 1: Patient Demographics.
Variable Number (%)
Number of patients 56
male 46 (80)
female 10 (20)
Mean age (years) 66 ± 11 (38–82)
Hypertension 32 (57)
Diabetes 14 (25)
History of PTCA restenosis 26 (46 )
Myocardial infarction 37 (66)
Chronic renal failure 2 (3)
Angina 54 (96)
Average preoperative LVEF 49 ± 6 (30–65)
Redo surgery 2 (3)
EuroScore 3.9 ± 2 (0–9)
PTCA: percutaneous angioplasty.
characteristics are summarized in Table 1.T h ep r o c e d u r e s
scheduled were a TECAB in 32 patients and a MIDCAB
in 24 patients. The TECAB procedure was proposed if the
coronary anatomy seemed favorable (large vessel > 3 mm,
nomajorcalciﬁcation,nointramyocardialcourse),andifthe
ejection fraction was normal. In other cases a MIDCAB was
proposed with harvesting of the LIMA or RIMA robotically
and the coronary anastomosis was done through a small
thoracotomy (left or right depending on the vessel).
Two patients were redo patients, both patients with
patent left-sided graft and occluded right venous grafts.
Twelve patients underwent hybrid procedures with surgical
revascularization on the LAD and angioplasty of another
vessel. All patients had a LIMA LAD anastomosis performed
while the other vessels stented were the right coronary (8
patients) and the circumﬂex (4 patients). The order of the
procedures varied as some patients had angioplasty prior
to surgery (4 patients), or surgery ﬁrst (8 patients). No
procedures were done simultaneously. Patients were always
discharged after the ﬁrst procedure and readmitted for the
second procedure.
The primary eﬃcacy endpoint of the study was the
composite endpoint of LIMA-LAD graft patency and free-
dom from target vessel reintervention during the period of
observation. The primary safety endpoints of the study were
freedom from major adverse cardiac events, including mor-
tality, target vessel reintervention, and myocardial infarction.
For each case, intraoperative times were determined
basedonperfusion,anesthesia,andoperativerecordsorwere
explicitly recorded during the operation. The details of the
surgicalprocedure,includingrevascularizationscheme,steps
of the surgical procedure that were completed robotically,
conversion to alternate techniques, time to conversion, and
reason for conversion, were documented in the operative
report forms.
3.2. In-Hospital Morbidity and In-Hospital Outcome. Nine
patients in the TECAB group had to be converted, 3 to
sternotomy and 6 to MIDCAB. Table 2 lists the cause of
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Figure 1: Operative time learning curves.
conversion and the outcome of the patients. No patients in
the MIDCAB group had to be converted to sternotomy.
3.3. Operative and ICU Data. In the 56 patients a total
of 59 anastomosis were completed as 4 patients had a
double bypass graft. The LAD was grafted in 77% (42),
diagonal branches in 5% (5), marginal branches in 3%
(2), and the right coronary artery and posterior descending
artery in 3% (3). Total operating time mammary artery
harvest and anastomosis time are reported in Table 3.T h e
“learning curve” is depicted graphically in Figure 1.T h e
mean reduction of time with increasing experience was
statistically signiﬁcant for total operative time, but not for
anastomosis or mammary artery harvesting.
Postoperative ventilation time was 6 ± 12 hours, ICU
length was 52 ± 23 hours, and hospital length of stay was
7.1 ± 3.5 days (range: 5–92 days).
3.4. Late Outcome. All patients were followed up for a
minimum of one year and the mean follow up was 13
± 36 months. One patient died in the hospital (1.7%) of
respiratory insuﬃciency at 6 days postoperatively. Autopsy
revealed ARDS and a patent LIMA-LAD graft. Two patients
died during follow up. One patient died of mesenteric
ischemia as revealed by autopsy at 4 months. One patient
developed gastric carcinoma and died 9 months post-
operatively. Of the 56 patients operated, 48 patients agreed
to have a postoperative angiogram (44 patients) or a gated
CT scan (4 patients). Eight patients asymptomatic refused
to undergo either coronary angiogram or gated scan. The
controls were performed at a minimum of three months and
a total of 52 anastomosis were controlled, with occlusion of
the graft in 4 patients and a signiﬁcant anastomotic stenosis
(<50%) in two patients. Of the 6 patients with anastomosis
dysfunction, three patients were reoperated: one underwent
angioplasty and two asymptomatic patients were treated
medically. Four patients refused either angiography or CT4 Cardiology Research and Practice
Table 2: Conversion and outcome.
Conversion Cause Angiogram Outcome
No 2 Sternotomy Intramyocardial LAD Patent Alive
No 4 Sternotomy Myocardial injury with trocar Patent Alive
No 10 Sternotomy Calciﬁed LAD Myocardial ischemia Patent Died of mesenteric ischemia (3 months)
No 13 MIDCAB Intramyocardial LAD Patent Alive
No 16 MIDCAB Small calciﬁed LAD Patent Alive
No 26 MIDCAB Robotic arm technical failure Patent Alive
No 29 MIDCAB Epicardial fat inability to visualize LAD Patent Alive
No 44 MIDCAB Ventilation problem Patent Alive
No 52 MIDCAB Robotic instruments technical failure Patent Alive
Table 3: Operative variable.
Variable Total n = 56
Total OR time (minutes) 274 ± 118
median 255
Mammary artery harvest (minutes) 53 ± 23
median 50
Anastomosis 30 ± 23
median 24
Double bypass 4
LAD diagonal 2
LAD right 2
Right circumﬂex 1
LAD circumﬂex 1
Single bypass 43
LAD 37
Diagonal 3
Right 2
Circumﬂex 1
Table 4: Adverse events.
Variable No. (%)
Mortality 1 (1.7)
Myocardial infarction 1 (1)
Target vessel reintervention 4 (6)
Reoperation for bleeding 2 (3)
Pleural eﬀusion 2 (3)
Pulmonary infection 2 (3)
Post cardiotomy syndrome 1 (1)
scan but are alive and symptom free one year after surgery.
Therefore the permeability rate is 48/52 or 92% and the
target vessel reintervention rate is 4/56, or 7%.
All together MACE events occurred in 8/56 patients
(14%) and are listed in Table 4: one in-hospital death, one
perioperativemyocardialinfarction,and4vesselsreinterven-
tions (as described above). Transfusion was required in only
4 patients (7.1%).
4. Comment
Single-vessel occluded coronary artery represents a small
group of patients with atheromatous coronary disease and
most of these patients are treated by mammary vessels
revascularization done through a sternotomy with or with-
out extracorporeal circulation according to the surgeon’s
preference and experience. Other patients present multiple
coronary vessel disease with one or two occluded vessels.
Some of these patients can be treated by a combination of
surgery for the occluded vessels and angioplasty on the other
vessels (hybrid revascularization) with excellent results and
a low morbidity [9–12]. Another possibility is to perform
a MIDCAB with harvesting of the mammary vessel and
coronary anastomosis done through a mini incision [13, 14].
Robotic surgery represents another option as the mammary
vessels can be harvested and the anastomosis done totally
endoscopically (TECAB) [8, 15]. Certainly many reports
haveshownthatTECABcanbedonewithapermeabilityrate
of 90% [16, 17]. However this permeability rate is certainly
inferior to surgery performed with extracorporeal bypass on
an arrested heart through a sternotomy, and this is reﬂected
in our studies which shows an 11% failure rate of the
anastomosis. Therefore the real question is whether TECAB
surgery should be performed or attempted since 5-year
results report 87% free from reintervention on the grafted
vessel [18]. It is diﬃcult to answer this question as also two
possibilities exist: TECAB with ECC or on a beating heart.
Ther ealanswerinor dertoimpr o v er esultsofr oboticsurgery
is patient’s selection. The robotic system now available
allows performing safely one-vessel revascularization and,
therefore, should be reserved for this group of patients.
Obviouslydouble-vesselortriplevesselrevascularizationcan
be done, but with increasing long operating time [19–22].
We have noted in our series that the longer the procedure is,
the more pulmonary comorbidities can occur, and therefore
the ICU time is increased. Also the anastomosis which is
one of the crucial elements of the procedure is always at the
end of the procedure when the team is loosing some of its
concentration. Therefore when the procedure becomes too
complex, we recommend switching to a MIDCAB procedure
which allows excellent results without long operating time
[22]. The selection of patients is extremely important for
this procedure. There are two aspects which should be
carefully reviewed. First the patient’s comorbidities shouldCardiology Research and Practice 5
be reviewed. As we have already mentioned, all patients with
pulmonary disease and/or poor ejection fraction should be
excludedsincepoor hemodynamic orlow cardiacoutput can
developduringtheprocedureduetoCO2 insuﬄationswhich
decreases venous return, and also cardiac stabilization which
sometimes decreases cardiac output. For these reasons we
routinely monitor cardiac output throughout the procedure
with a radial monitor. When cardiac output decreases and
is not improved despite simple measures (adding extra
volume), we generally convert to a MIDCAB procedure
[23]. The other aspects which should be carefully reviewed
are the location, quality, and trajectory of the target vessel.
Therefore, we have performed preoperative gated CT scan
which allows us to appreciate the degree of calciﬁcations and
the portion of the artery either intramyocardial or epicardial.
This remains more important than in open surgery as the
artery sometimes can be quite diﬃcult to ﬁnd if the vessel
is in the fat or intramyocardial. Also if the vessel is calciﬁed,
it can be more diﬃcult to perform the anastomosis with the
robot. So we think that diﬀuse calciﬁed and intramyocardial
vesselsshouldbeexclusioncriteriafortheTECABprocedure.
Finally the diameter of the vessel is important. It is diﬃcult
to select a number as to which to recommend not to attempt
a TECAB, but certainly the bigger the vessel, the easier the
anastomosis and better the result will be. Occluded arteries
areanidealsituationsincethereisrarelyanyischemiaduring
vessels occlusion, and therefore the time to perform the
coronary anastomosis is not an issue. Another interesting
group of patients are redo coronary surgery. Sometimes only
one vessel needs to be revascularised as the other grafts
are still patent and certainly mini access or robotic surgery
can be a simple option [24]. It avoids redo sternotomy and
its complications; the stabilization of the heart is usually
simpler as the adhesions decrease the beating motion of the
myocardium. However it can be sometimes diﬃcult to ﬁnd
the target vessel and a preoperative CT scan can help in
ﬁnding the vessel.
The length of stay in this study was 7 days which is not
much diﬀerent then forsternotomy patients. This is certainly
much higher than in various countries but is the norm in
our country where patients are kept around a week in the
hospital before being sent to a rehabilitation center. However
most of the patients (48/56) were discharged directly home,
whereas the patient who underwent a sternotomy was sent to
a rehabilitation center.
5. Conclusion
Robotic coronary surgery is basically feasible and can be
performed, but with a high conversion rate and a lower
permeability rate than conventional surgery. Selection of the
patient and also of the target vessel is extremely important
to avoid conversion or poor vessel patency. In case of
hemodynamic instability or increased diﬃculty occurring
during the surgery, quick conversion should be performed.
New techniques are needed in order to improve permeability
rates.
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